41651-87-0

Upstream product

• 152120-54-2 N,N'-bis( tert-butoxycarbonyl)-1H-pyrazole-1-carboxamidine 
• 164470-64-8 N-(9-fluorenylmethyloxycarbonyl)-4-(aminomethyl)benzoic acid 
• 56-91-7 p-aminomethylbenzoic acid 
• 29427-58-5 O-methylisourea hemisulfate 
• 145013-05-4 tert-butyl N-({[(tert-butoxy)carbonyl]amino}methanethioyl)carbamate 
• 867-44-7 S-Methylisothiourea sulfate 

Downstream Products

• 126637-58-9 4-Guanidinomethyl-benzoic acid 2,5-dioxo-pyrrolidin-1-yl ester 
• 1417564-72-7 C₁₉H₁₅N₅O₂ 
• 1417564-73-8 C₁₈H₁₄N₆O₂ 
• 1417564-74-9 C₁₈H₁₄N₆O₂ 
• 1423121-63-4 C₂₀H₁₆BrN₅O₂ 
• 1417564-75-0 C₂₀H₁₇N₅O₂ 
• 1417564-76-1 C₁₉H₁₆N₆O₂ 
• 1417564-77-2 C₁₉H₁₆N₆O₂ 

Relevant academic research and scientific papers

Syntheses and inhibitory effects on gastric lesions of 4- guanidinomethylbenzoic acid arylamides

A novel series of 4-guanidinomethylbenzoic acid (GMBA) arylamides was synthesized. Several showed more potent inhibitory effects on stress-induced gastric lesion in rats than cetraxate. We selected 4-guanidinomethylbenzoic acid (2'-ethoxycarbonyl)phenylam

Solid phase synthesis of guanidines

A comparison of guanylating agents 1 and 2 was performed on a series of primary, secondary and aromatic amines in solution and on solid phase resins. Thiourea 1 performed well in solution and on solid supported primary and secondary amines. Pyrazole 2 per

A specific anti-Helicobacter pylori agent NE2001: Synthesis and its effect on the growth of H. pylori

The synthesis and anti-Helicobacter pylori activity of a novel agent NE2001, 4-(4-methylbenzyl)-4′-[guanidinomethylbenzoyloxy] biphenyl-4-carboxylate hydrochloride, are described. NE2001 had a specific inhibitory effect on the growth of H. pylori preceded by the suppression DNA synthesis in the cell. The effects of NE2001 on RNA and protein syntheses in H. pylori were also examined.